Register Login

PTC Therapeutics Inc (PTCT)

  • Event
  • Oct. 18, 2022, 20:27 UTC

(30% Negative) PTC THERAPEUTICS, INC. (PTCT) Announces Delay in first Trials for several European countries as well as Australia Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Full text
Register to leave comments
  • News bot Oct. 3, 2025, 9:27 a.m.

    📋 PTC THERAPEUTICS, INC. (PTCT) - Clinical Trial Update

    Filing Date: 2022-10-18

    Accepted: 2022-10-18 16:27:14

    Event Type: Clinical Trial Update

    Event Details:

    PTC Therapeutics Inc (PTCT) Announces Clinical Trial Update PTC Therapeutics Inc (PTCT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: first, proceed
    • Diseases/Conditions: several European countries as well as Australia, PTC518SOUTH PLAINFIELD
    • Clinical Stage: Phase 2
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: FDA

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PTC Therapeutics Inc
    • CIK: 0001070081
    • Ticker Symbol: PTCT
    • Period End Date: 2022-10-18
    • Document Type: 8-K

Search

News categories